Jeffrey L. Bennett

1986–2025 年に発表

105
論文数
19,019
被引用数
66
h 指数
97
i10 指数

被引用数

Jeffrey L. Bennett の年別被引用数1986 年: 被引用 2 件1988 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 5 件2003 年: 被引用 1 件2004 年: 被引用 2 件2005 年: 被引用 2 件2006 年: 被引用 3 件2007 年: 被引用 4 件2008 年: 被引用 12 件2009 年: 被引用 20 件2010 年: 被引用 52 件2011 年: 被引用 86 件2012 年: 被引用 111 件2013 年: 被引用 142 件2014 年: 被引用 102 件2015 年: 被引用 113 件2016 年: 被引用 142 件2017 年: 被引用 140 件2018 年: 被引用 147 件2019 年: 被引用 598 件2020 年: 被引用 782 件2021 年: 被引用 761 件2022 年: 被引用 688 件2023 年: 被引用 566 件2024 年: 被引用 1,010 件2025 年: 被引用 479 件2026 年: 被引用 2 件1987 年は被引用が無いため表示していません1989〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,243 件、この内訳の 19.9%ドイツ: 引用元論文 578 件、この内訳の 9.2%イギリス: 引用元論文 486 件、この内訳の 7.8%中国: 引用元論文 441 件、この内訳の 7.1%イタリア: 引用元論文 353 件、この内訳の 5.6%フランス: 引用元論文 253 件、この内訳の 4%日本: 引用元論文 249 件、この内訳の 4%カナダ: 引用元論文 193 件、この内訳の 3.1%スペイン: 引用元論文 185 件、この内訳の 3%スイス: 引用元論文 177 件、この内訳の 2.8%オランダ: 引用元論文 176 件、この内訳の 2.8%オーストリア: 引用元論文 174 件、この内訳の 2.8%
0%19.9%その他 27.9%

分野

  • Medicine80.4%
  • Neuroscience7.7%
  • Biochemistry, Genetics and Molecular Biology6.2%
  • Immunology and Microbiology4.3%
  • Engineering0.3%
  • Chemistry0.2%
  • その他0.9%

トピック

  • Multiple Sclerosis Research Studies19.9%
  • Peripheral Neuropathies and Disorders11.6%
  • Autoimmune Neurological Disorders and Treatments4.3%
  • Systemic Lupus Erythematosus Research3.9%
  • Neuroinflammation and Neurodegeneration Mechanisms3.8%
  • T-cell and B-cell Immunology2.1%
  • その他54.4%

共著者

全論文

検索で開く
  1. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

    著者: , , , , , , , , , , , , , , , , , , - Neurology 2015 被引用: 4,543

  2. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2023 被引用: 1,130

  3. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 被引用: 717

  4. Myelin-oligodendrocyte glycoprotein antibody-associated disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Krzysztof Selmaj, Aksel Sıva, Bruno Stankoff, Mar Tintoré, Anthony Traboulsee, Patrick Waters, Emmanuelle Waubant, Brian G. Weinshenker, Tobias Derfuß, Sandra Vukusic, Bernhard Hemmer - The Lancet Neurology 2021 被引用: 517

  5. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2009 被引用: 856

  6. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

    著者: , , , , , , , , , , , , - The Lancet Neurology 2020 被引用: 490

  7. Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder

    著者: , , , , , , , , , , , , , , - Annals of Neurology 2023 被引用: 191

  8. Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology

    著者: , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2020 被引用: 246

  9. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment

    著者: , , , , , , - The Lancet Neurology 2022 被引用: 202

  10. Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , - The Lancet Neurology 2020 被引用: 272

  11. Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Ophthalmology 2018 被引用: 400

  12. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ann Herman, Christopher Harp, Amit Bar‐Or - JAMA Neurology 2024 被引用: 92

  13. International Delphi Consensus on the Management of AQP4-IgG+ NMOSD

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2023 被引用: 86

  14. MRI characteristics of neuromyelitis optica spectrum disorder

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean Wingerchuk, Ho Jin Kim, Lekha Pandit, Ilya Kister, Maria Isabel Leite, Jacqueline Palace, Metha Apiwattanakul, Ingo Kleiter, Naraporn Prayoonwiwat, May Han, Kerstin Hellwig, Brenda Banwell, Katja Van Herle, Jacinta M. Behne, Gareth John, D. Craig Hooper, Kazuo Fujihara, Ichiro Nakashima, Douglas Kazutoshi Sato, Anthony Traboulsee, Michael R. Yeaman, Emmanuelle Waubant, Scott Zamvil, Jeffrey L. Bennett, Marco Aurélio Lana–Peixoto, Benjamin Greenberg, Olaf Stüve, Orhan Aktaş, Jens Wuerfel, Terry J. Smith, Nasrin Asgari, Anu Jacob, Kevin C. O’Connor - Neurology 2015 被引用: 650

  15. Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica

    著者: , , , , , , , , , , , , , - Annals of Neurology 2009 被引用: 586

  16. Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker

    著者: , , , , , , , - Annals of Neurology 2021 被引用: 136

  17. Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar

    著者: , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2022 被引用: 66

  18. Treatment of MOG antibody associated disorders: results of an international survey.

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Apiwattankul, Jyh Yung Hor, S Viswanathan, Wei Qiu, Han Jo Kim, Ichiro Nakashima, Kazuo Fujihara, Sudarshini Ramanathan, Russell C. Dale, M. Boggild, Simon Broadley, M. A. Lana-Peixoto, Douglas Kazutoshi Sato, Sílvia Tenembaum, P. Cabré, Dean M. Wingerchuk, Brian G. Weinshenker, Benjamin Greenberg, Marcelo Matiello, Eric C. Klawiter, Jeffrey L. Bennett, Asya I. Wallach, Ilya Kister, Brenda Banwell, Anthony Traboulsee, Daniela Pohl, Jacqueline Palace, Maria Isabel Leite, Michael Levy, Romain Marignier, Tom Solomon, Ming Lim, Saif Huda, A. Jacob - 2020 被引用: 138

  19. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hadas Stiebel‐Kalish, Sean J. Pittock - Neurology 2020 被引用: 231

  20. Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie Pique, Eoin P. Flanagan, Romain Marignier - JAMA Neurology 2022 被引用: 112

  21. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher Harp, Ann Herman, Amit Bar‐Or - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 被引用: 58

  22. Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis

    著者: , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2022 被引用: 56

  23. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo

    著者: , , , , , - Experimental Neurology 2019 被引用: 119

  24. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rinze F. Neuteboom, Cheryl Hemingway, Rob Forsyth, Marcelo Matiello, Stewart Webb, David Hunt, Katy Murray, Yael Hacohen, Ming Lim, Maria Isabel Leite, Jacqueline Palace, Tom Solomon, Andreas Lutterotti, Kazuo Fujihara, Ichiro Nakashima, Jeffrey L. Bennett, Lekha Pandit, Tanuja Chitnis, Brian G. Weinshenker, Brigitte Wildemann, Douglas Kazutoshi Sato, Su‐Hyun Kim, Saif Huda, Ho Jin Kim, Markus Reindl, Michael Levy, Sven Jarius, Sílvia Tenembaum, Friedemann Paul, Sean J. Pittock, Romain Marignier, Anu Jacob - Multiple Sclerosis and Related Disorders 2020 被引用: 179